{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:01:57Z","timestamp":1770717717854,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1995,7,1]]},"DOI":"10.1038\/nm0795-681","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:12:59Z","timestamp":1092877979000},"page":"681-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate"],"prefix":"10.1038","volume":"1","author":[{"given":"Hiroki","family":"Bukawa","sequence":"first","affiliation":[]},{"given":"Ken-Ichiro","family":"Sekigawa","sequence":"additional","affiliation":[]},{"given":"Kenji","family":"Hamajima","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Fukushima","sequence":"additional","affiliation":[]},{"given":"Yoshihiko","family":"Yamada","sequence":"additional","affiliation":[]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[]},{"given":"Kenji","family":"Okuda","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0795681_CR1","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.1360702","volume":"258","author":"T Lehner","year":"1992","unstructured":"Lehner, T. et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258, 1365\u20131369 (1992).","journal-title":"Science"},{"key":"BFnm0795681_CR2","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1073\/pnas.90.18.8638","volume":"90","author":"T Lehner","year":"1993","unstructured":"Lehner, T. et al. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc. natn. Acad. Sci. U.SA. 90, 8638\u20138642 (1993).","journal-title":"Proc. natn. Acad. Sci. U.SA."},{"key":"BFnm0795681_CR3","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/jvi.68.3.1624-1632.1994","volume":"68","author":"T Lehner","year":"1994","unstructured":"Lehner, T. et al. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol 68, 1624\u20131632 (1994).","journal-title":"J. Virol"},{"key":"BFnm0795681_CR4","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.4049\/jimmunol.152.9.4642","volume":"152","author":"PR Burnett","year":"1994","unstructured":"Burnett, P.R., VanCott, T.C., Polonis, V.R., Redfield, R.R. & Birx, D.L., IgA-mediated neutralization of HIV type 1. J. Immun. 152, 4642\u20134648 (1994).","journal-title":"J. Immun."},{"key":"BFnm0795681_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/jmr.300060302","volume":"6","author":"K Okuda","year":"1993","unstructured":"Okuda, K. et al. Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection. J. Molec. Recognition 6, 101\u2013109 (1993).","journal-title":"J. Molec. Recognition"},{"key":"BFnm0795681_CR6","first-page":"97","volume":"40","author":"K Okuda","year":"1993","unstructured":"Okuda, K. et al. Strong synergistic effects of multicomponent vaccine for human immunodeficiency virus infection. J. clin. lab. Immun. 40, 97\u2013113 (1993).","journal-title":"J. clin. lab. Immun."},{"key":"BFnm0795681_CR7","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1128\/iai.61.10.4272-4279.1993","volume":"61","author":"RJ Rockson","year":"1993","unstructured":"Rockson, R.J. et al. Optimizing oral vaccines: Induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect Immun. 61, 4272\u20134279 (1993).","journal-title":"Infect Immun."},{"key":"BFnm0795681_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1084\/jem.178.4.1309","volume":"178","author":"J Xu-Amano","year":"1993","unstructured":"Xu-Amano, J. et al. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. exp. Med. 178, 1309\u20131320 (1993).","journal-title":"J. exp. Med."},{"key":"BFnm0795681_CR9","first-page":"301","volume":"59","author":"N Lycke","year":"1986","unstructured":"Lycke, N. & Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301\u2013308 (1986).","journal-title":"Immunology"},{"key":"BFnm0795681_CR10","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/00002030-199109000-00015","volume":"5","author":"S Inami","year":"1991","unstructured":"Inami, S. et al. Serum antibody directed against synthetic peptides derived from HIV-1 protein sequence obtained from 26 Japanese HIV-1-infected individuals. AIDS 5, 1140\u20131141 (1991).","journal-title":"AIDS"},{"key":"BFnm0795681_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/infdis\/169.1.227","volume":"169","author":"K Okuda","year":"1994","unstructured":"Okuda, K. et al. A serogic analysis and the amino acid sequence of the V3 region of human immunodeficiency virus from carriers in Bangkok. J. infect. Dis. 169, 227\u2013228 (1994).","journal-title":"J. infect. Dis."},{"key":"BFnm0795681_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(94)91825-2","volume":"344","author":"S Ubolyam","year":"1994","unstructured":"Ubolyam, S., Ruxrungtham SirMchayakul, S., Okuda, K. & Phanuphak, P. Evidence of three HIV-1 subtypes in subgroups of individuals in Thailand. Lancet 344, 485\u2013486 (1994).","journal-title":"Lancet"},{"key":"BFnm0795681_CR13","unstructured":"Bukawa, H. et al. Antibody responses raised against a conformational V3 loop peptide of HIV-1. Micorbiol Immun. (in the press)."},{"key":"BFnm0795681_CR14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0042-6822(92)90249-O","volume":"191","author":"JA McKeating","year":"1992","unstructured":"McKeating, J.A., Cordell, J., Dean, C.J. & Balfe, P. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191, 732\u2013742 (1992).","journal-title":"Virology"},{"key":"BFnm0795681_CR15","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1073\/pnas.87.18.7045","volume":"87","author":"A Achour","year":"1990","unstructured":"Achour, A. et al. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc. natn. Acad. Sci. U.S.A. 87, 7045\u2013049 (1990).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFnm0795681_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jcla.1860040109","volume":"4","author":"CAB Boucher","year":"1990","unstructured":"Boucher, C.A.B. et al. Immune response and epitope mapping of a candidate HIV-1 pl7 vaccine HGP30. J. clin. Lab. Anal. 4, 43\u201347 (1990).","journal-title":"J. clin. Lab. Anal."},{"key":"BFnm0795681_CR17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4049\/jimmunol.148.3.914","volume":"148","author":"B Nardelli","year":"1992","unstructured":"Nardelli, B. et al. A chemically defined synthetic vaccine model for HIV-1. J. Immun. 148, 914\u2013920 (1992).","journal-title":"J. Immun."},{"key":"BFnm0795681_CR18","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1073\/pnas.89.9.3879","volume":"89","author":"J-P Defoort","year":"1992","unstructured":"Defoort, J.-P., Nardelli, B., Huang, W., Ho, D.D. & Tam, J.P. Macromolecular assemblage in the design of a synthetic AIDS vaccine. Proc. natn. Acad. Sci. U.S.A. 89, 3879\u20133883 (1992).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFnm0795681_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0022-2836(72)90206-9","volume":"65","author":"AH Korn","year":"1972","unstructured":"Korn, A.H., Feairheller, S.H. & Filachione, E.M., Nature of the reagent. J. molec. Biol 65, 525\u2013529 (1972).","journal-title":"J. molec. Biol"},{"key":"BFnm0795681_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0076-6879(80)70047-2","volume":"70","author":"M Reichlin","year":"1980","unstructured":"Reichlin, M. Use of glutaraldehyde as a coupling agent for proteins and peptides. Meth. Enzym. 70, 159\u2013165 (1980).","journal-title":"Meth. Enzym."},{"key":"BFnm0795681_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/0952-7915(94)90144-9","volume":"6","author":"HF Staats","year":"1994","unstructured":"Staats, H.F. et al. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immun. 6, 572\u2013583 (1994).","journal-title":"Curr. Opin. Immun."},{"key":"BFnm0795681_CR22","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/iai.61.5.2082-2088.1993","volume":"61","author":"I Bourguin","year":"1993","unstructured":"Bourguin, I., Chardes, T. & Bout, D. Oral immunization with Toxoplasma gondiiantigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57\/BL\/6 mice. Infect. Immun. 61, 2082\u20132088 (1993).","journal-title":"Infect. Immun."},{"key":"BFnm0795681_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/aid.1987.3.283","volume":"3","author":"PL Nara","year":"1987","unstructured":"Nara, P.L. et al. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. hum. Retrovir. 3, 283\u2013302 (1987).","journal-title":"AIDS Res. hum. Retrovir."},{"key":"BFnm0795681_CR24","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1126\/science.2431482","volume":"234","author":"SD Putney","year":"1986","unstructured":"Putney, S.D. et al. HTLV-III\/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 234, 1392\u20131395 (1986).","journal-title":"Science"},{"key":"BFnm0795681_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","volume":"20","author":"R Pauwels","year":"1988","unstructured":"Pauwels, R. et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. virol. Meth. 20, 309\u2013321 (1988).","journal-title":"J. virol. Meth."},{"key":"BFnm0795681_CR26","first-page":"169","volume":"37","author":"H Nakashima","year":"1990","unstructured":"Nakashima, H. Development of anti-human immunodeficiency virus (HIV) agents. Bull. Yamaguchi Med. Sch. 37, 169\u2013180 (1990).","journal-title":"Bull. Yamaguchi Med. Sch."},{"key":"BFnm0795681_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/aid.1990.6.205","volume":"6","author":"PK Lai","year":"1990","unstructured":"Lai, P.K. et al. Modification of human immunodeficiency viral replication by pine cone extracts. AIDS Res. hum. Retrovir. 6, 205\u2013217 (1990).","journal-title":"AIDS Res. hum. Retrovir."},{"issue":"8500","key":"BFnm0795681_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0140-6736(86)92485-2","volume":"328","author":"Jaap Goudsmit","year":"1986","unstructured":"Goudsmit, J. et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 2, 177\u2013180(1986).","journal-title":"The Lancet"},{"key":"BFnm0795681_CR29","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1073\/pnas.78.7.4557","volume":"78","author":"K Okuda","year":"1981","unstructured":"Okuda, K., Minami, M., Ju, S.-T. & Dorf, M.E. Functional association of idio-typic and I-J determinants on the antigen receptor of suppressor T cells. Proc. natn. Acad. Sci. U.SA. 78, 4557\u20134561 (1981).","journal-title":"Proc. natn. Acad. Sci. U.SA."},{"key":"BFnm0795681_CR30","first-page":"319","volume":"1","author":"T Lehner","year":"1992","unstructured":"Lehner, T. et al. A comparison of the immune responses following oral, vaginal, or rectal route of immunization with SIV antigens in nonhuman primates. Vaccine Res. 1, 319\u2013330 (1992).","journal-title":"Vaccine Res."},{"key":"BFnm0795681_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-3083.1978.tb00448.x","volume":"7","author":"M Kaartinen","year":"1978","unstructured":"Kaartinen, M., Imir, T., Klockars, M., Sandholm, M. & M\u00e4kel\u00e4, O. IgA in blood and thoracic duct lymph: Concentration and degree of polymerization. Scand. J. Immun. 7, 229\u2013232 (1978).","journal-title":"Scand. J. Immun."},{"key":"BFnm0795681_CR32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1073\/pnas.86.3.1031","volume":"86","author":"CA Olson","year":"1989","unstructured":"Olson, C.A., Williams, L.C., McLaughlin-Taylor, E. & McMillan, M. Creation of H-2 class I epitopes using synthetic peptides: Recognition by alloreactive cytotoxic T lymphocytes. Proc. natn. Acad. Sci. U.SA. 86, 1031\u20131035 (1989).","journal-title":"Proc. natn. Acad. Sci. U.SA."},{"key":"BFnm0795681_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0022-1759(91)90155-9","volume":"141","author":"T deVos","year":"1991","unstructured":"deVos, T. & Dick, T.A. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. immunoh Meth. 141, 285\u2013288 (1991).","journal-title":"J. immunoh Meth."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm0795-681","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm0795-681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm0795-681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:09:19Z","timestamp":1744283359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0795-681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7,1]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1995,7,1]]}},"alternative-id":["BFnm0795681"],"URL":"https:\/\/doi.org\/10.1038\/nm0795-681","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7,1]]},"assertion":[{"value":"3 April 1995","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 1995","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}